Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 103695953 | 10369595 | 3 | F | 20160210 | 20140807 | 20160922 | PER | US-AMGEN INC.-USASP2014021123 | AMGEN | 56.00 | YR | A | F | Y | 0.00000 | 20160922 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 103695953 | 10369595 | 1 | PS | NEUPOGEN | FILGRASTIM | 1 | Subcutaneous | 480 MUG, UNK | U | 103353 | 480 | UG | UNKNOWN FORMULATION | ||||||
| 103695953 | 10369595 | 2 | SS | HERCEPTIN | TRASTUZUMAB | 1 | Intravenous (not otherwise specified) | 270 MG, UNK | 0 | 270 | MG | SOLUTION FOR INFUSION | |||||||
| 103695953 | 10369595 | 3 | SS | HERCEPTIN | TRASTUZUMAB | 1 | Intravenous (not otherwise specified) | 135 MG, UNK | 0 | 135 | MG | SOLUTION FOR INFUSION | |||||||
| 103695953 | 10369595 | 4 | SS | BACTRIM | SULFAMETHOXAZOLETRIMETHOPRIM | 1 | Unknown | UNK | 0 | ||||||||||
| 103695953 | 10369595 | 5 | C | ATIVAN | LORAZEPAM | 1 | 0.5 MG, UNK | 0 | .5 | MG | |||||||||
| 103695953 | 10369595 | 6 | C | ALOXI | PALONOSETRON HYDROCHLORIDE | 1 | 0.75 MG, UNK | 0 | .75 | MG | |||||||||
| 103695953 | 10369595 | 7 | C | COMPAZINE | PROCHLORPERAZINE MALEATE | 1 | Oral | 10 MG, UNK | 0 | 10 | MG | ||||||||
| 103695953 | 10369595 | 8 | C | TAXOTERE | DOCETAXEL | 1 | 130 MG, UNK | 0 | 130 | MG | |||||||||
| 103695953 | 10369595 | 9 | C | EMEND | APREPITANT | 1 | 150 MG, UNK | 0 | 150 | MG | |||||||||
| 103695953 | 10369595 | 10 | C | NEULASTA | PEGFILGRASTIM | 1 | Intravenous (not otherwise specified) | UNK | 0 | UNKNOWN FORMULATION | |||||||||
| 103695953 | 10369595 | 11 | C | ZOFRAN | ONDANSETRON HYDROCHLORIDE | 1 | Intravenous (not otherwise specified) | UNK | 0 | ||||||||||
| 103695953 | 10369595 | 12 | C | DEXAMETHASONE. | DEXAMETHASONE | 1 | 20 MG, UNK | 0 | 20 | MG | |||||||||
| 103695953 | 10369595 | 13 | C | CARBOPLATIN. | CARBOPLATIN | 1 | 600 MG, UNK | 0 | 600 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 103695953 | 10369595 | 1 | Breast cancer |
| 103695953 | 10369595 | 2 | Breast cancer |
| 103695953 | 10369595 | 4 | Product used for unknown indication |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 103695953 | 10369595 | Abdominal pain | |
| 103695953 | 10369595 | Drug hypersensitivity | |
| 103695953 | 10369595 | Eye disorder | |
| 103695953 | 10369595 | Fatigue | |
| 103695953 | 10369595 | Local swelling |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 103695953 | 10369595 | 1 | 20110729 | 20110729 | 0 | |
| 103695953 | 10369595 | 2 | 20110715 | 20110715 | 0 | |
| 103695953 | 10369595 | 3 | 20110722 | 20110722 | 0 | |
| 103695953 | 10369595 | 5 | 20110715 | 20110715 | 0 | |
| 103695953 | 10369595 | 6 | 20110715 | 20110715 | 0 | |
| 103695953 | 10369595 | 7 | 20110722 | 20110722 | 0 | |
| 103695953 | 10369595 | 8 | 20110715 | 20110715 | 0 | |
| 103695953 | 10369595 | 9 | 20110715 | 20110715 | 0 | |
| 103695953 | 10369595 | 10 | 20110919 | 20110919 | 0 | |
| 103695953 | 10369595 | 11 | 20110919 | 20110919 | 0 | |
| 103695953 | 10369595 | 12 | 20110715 | 20110715 | 0 | |
| 103695953 | 10369595 | 13 | 20110715 | 20110715 | 0 |